The BoneGuide team is one step closer to making its transformative bone healing technology available to healthcare providers and patients alike. BoneGuide is a project of Charité - Universitätsmedizin Berlin and is supported by Charité BIH Innovation. On May 1, 2024, Aaron Herrera and his team will officially enter the first phase of the EXIST…
Workshop “Team up Smart – match skill and will” Identify your personality strengths and explore your best-fit within a team In this workshop, you will learn to match your personality skills with your will! Explore your personal strengths, and learn to leverage them in a team setting. An experienced coach will guide this four-hour session by…
Workshop "Serious Transfer Game @BIH-Charité: Play your way through the options of technology transfer" Your research results are relevant for practical application, but the numerous options open to you in technology transfer are confusing - where should you start? What should you do? In this interactive and innovative serious game, you as a group…
Aignostics, a spin-off of Charité – Universitätsmedizin Berlin and alumnus of the Berlin Institute of Health Digital Health Accelerator Program, has been named to Newsweek’s inaugural ranking of the “World’s Best Digital Health Companies 2024.”
Charité/BIH and Enterprise Singapore (ESG) have established an innovation support program that promotes cooperation between excellent clinicians from Charité/BIH and start-ups from Singapore. Following the successful application of start-ups from Singapore, we are now looking for project partners at Charité/BIH.
Co-innovation programme between Enterprise Singapore and Charite/BIH In November 2023, the signing of a Memorandum of Understanding (MoU) between Charité - Universitätsmedizin Berlin, the Berlin Institute of Health (BIH) and Enterprise Singapore for a co-innovation program laid the foundation for a professional network of start-ups from Singapore…
Program and call for proposals The aim of the current call (start 01.03.2024) at Enterprise Singapore is to shape our partnership through transnational project work. New technologies and medical innovations from Singapore companies are to be further developed together with Charité and BIH researchers so that they can be made available to patients…
Background In November 2023, a Memorandum of Understanding was signed between Charité-Universitätsmedizin Berlin, the Berlin Institute of Health Sciences and Enterprise Singapore, the Singapore government agency championing enterprise development, with the aim of strengthening international collaboration and translational research. Building on this…
Agenda Table Process stage Deadline Publication of the call 01.03.2024 Startups submit Expression of Interest (EoI) to Enterprise Singapore April 2024 First phase: Startups and Charité/BIH employees are "matched", (Letter of Intent, LoI from Charité/BIH employees), shortlist of selected startups for second phase is submitted to ES May 2024 Second…
Startups The short profiles of the startups can be found here: Short profiles Acumen Diagnostics Medical field: Infectious diseases Product type: Medical devices, diagnostics and therapeutics Growth stage: Development Team: 30 people Description of product: Unyvero A30 SHR (Sepsis Host Response) is a blood-based, host response gene expression test,…